Using differential display techniques, an initial survey using rats RNA expression of c-H-Ras was decreased and p53 increased in rats with chronic vitamin A deficiency findings prompted us
Trang 1In vivo studies of altered expression patterns of p53 and proliferative control genes in chronic vitamin A deficiency and hypervitaminosis
Elisa Borra´s, Rosa Zaragoza´, Marı´a Morante, Concha Garcı´a, Amparo Gimeno, Gerardo Lo´pez-Rodas,
Teresa Barber, Vicente J Miralles, Juan R Vin˜a and Luis Torres
1
Departamento de Bioquı´mica y Biologı´a Molecular, Facultades de Medicina y Farmacia., Universidad de Valencia, Valencia, Spain
Several clinical trials have revealed that individuals who were
given b)carotene and vitamin A did not have a reduced risk
of cancer compared to those given placebo
vita-min A could actually have caused an adverse effect in the
lungs of smokers [Omenn, G.S., Goodman, G.E.,
Thorn-quist, M.D., Balmes, J., Cullen, M.R., Glass, A., Keogh,
J.P., Meyskens, F.L., Valanis, B., Williams, J.H., Barnhart,
S & Hammar, S N Engl J Med (1996) 334, 1150–1155;
Hennekens, C.H., Buring, J.E., Manson, J.E., Stampfer, M.,
Rosner, B., Cook, N.R., Belanger, C., LaMotte, F.,
Gazi-ano, J.M., Ridker, P.M., Willet, W & Peto, R (1996)
N Engl J Med 334, 1145–1149] Using differential display
techniques, an initial survey using rats
RNA expression of c-H-Ras was decreased and p53
increased in rats with chronic vitamin A deficiency
findings prompted us to evaluate the expression of c-Jun, p53
and p21WAF1/CIF1(by RT-PCR) in liver and lung of rats This
study showed that c-Jun levels were lower and that p53 and
p21WAF1/CIF1 levels were higher in chronic vitamin A
deficiency Vitamin A supplementation increased expression
of c-Jun, while decreasing the expression of p53 and p21WAF1/CIF1 Western-blot analysis demonstrated that c-Jun and p53 showed a similar pattern to that found in the RT-PCR analyses Binding of retinoic acid receptors (RAR)
to the c-Jun promoter was decreased in chronic vitamin A deficiency when compared to control hepatocytes, but contrasting results were found with acute vitamin A sup-plementated cells DNA fragmentation and cytochrome c release from mitochondria were analyzed and no changes were found In lung, an increase in the expression of c-Jun produced a significant increase in cyclin D1 expression These results may explain, at least in part, the conflicting results found in patients supplemented with vitamin A and illustrate that the changes are not restricted to lung Furthermore, these results suggest that pharmacological vitamin A supplementation may increase the risk of adverse effects including the risk of oncogenesis
Keywords: vitamin A; retinoic acid; p53; cyclin D1; c-Jun
Vitamin A (retinol) is an essential nutrient that is
metabo-lized in mammalian cells to retinal and retinoic acid The
latter shares some of the activities of retinol but is unable to
support processes such as vision (11-cis-retinal) Retinoids
exert their effects by binding to specific receptors that
comprise two subfamilies, RARs (retinoic acid receptors)
and RXRs (retinoid X/cis RAR) [1,2] A variety of studies
have shown that vitamin A is necessary for normal growth
and development through control of gene expression [3–9]
Vitamin A has other important effects; it can function
as a pro-oxidant or as an antioxidant The antioxidant
properties of vitamin A have been shown both in vitro
and in vivo [10–12] Vitamin A deficiency causes oxidative
damage to liver mitochondria in rats that can be reversed by
vitamin A supplementation [13] However, the addition of
retinol and retinal to cultures of HL-60 cells causes cellular
DNA cleavage and an increased formation of
8-oxo-7,8-dihydro-2¢-deoxyguanosine via superoxide generation [14]; moreover, in vitro, it has been shown that b-carotene cleavage products induce oxidative stress by impairing mitochondrial respiration [15] Therefore, maintaining the vitamin A concentration within the physiological range is critical to normal cell function because either a deficiency or
an excess of vitamin A induces oxidative stress
This study was undertaken to identify genes that may be regulated by vitamin A Liver and lung were evaluated in normal, chronic vitamin A deficient and vitamin A supple-mented rats by the technique of differential display As expression of c-H-Ras was found to be lower and that of p53
7
was higher in chronic vitamin A deficiency and c-H-Ras and p53play an inverse role in the control of cellular prolifer-ation, related genes were studied by RT-PCR The results presented here emphasize the importance of vitamin A in controlling the expression of p53 and related genes that are essential for maintaining the integrity of tissues
Materials and methods
Rats Wistar rats (Charles River Lab., Barcelona, Spain) were8,9,10
given a vitamin A deficient, solid diet.Pregnant rats were8,9,108,9,10
housed in individual cages in a room maintained at 22C
Correspondence to J R Vin˜a, Departamento de Bioquı´mica y
Biologı´a Molecular, Facultad de Medicina, Universidad de
Valencia, Avenue Blasco Iban˜ez 17, Valencia-46010, Spain.
E-mail: Juan.R.Vina@uv.es
Abbreviations: RAR, retinoic acid receptors.
(Received 24 October 2002, revised 14 January 2003,
accepted 20 January 2003)
Trang 2with a 12-h light : 12-h dark cycle Rats were cared and
handled in conformence with the Guiding Principles for
Research Involving Animals and Humans, approved by the
Council of the American Physiological Soceity The School
of Medicine Research Committee approved this study One
day after pup birth, dams were fed either a control diet or
vitamin A-deficient diet Milk production was evaluated
during lactation in both groups After weaning, the rats
were fed the same corresponding diet until 50 days old [13]
A third group of rats received a daily peritoneal injection of
vitamin A (200 000 IU all trans-retinol palmitate per kg
body weight) over a period of 5 days
The trans-retinol palmitate (type VII: synthetic Sigma)
was dissolved in NaCl 0.15M The control rats for the latter
group were injected with NaCl, 0.15 M over a period of
5 days
Retinoid determination
The experiments were performed between 10.00 h and
12.00 h Rats were anesthetized with Pentothal (50 mgÆkg)1
body weight, intraperitoneally) Blood was collected from
the aorta in heparinized syringes and then liver and lung
samples were taken and processed immediately
Retinol and retinyl palmitate were measured in serum
and tissues following the method described by Barua and
Olson [16]
Differential display analysis
Liver RNA was isolated by extraction with the guanidinium
thiocyanate method followed by centrifugation in a cesium
chloride solution as described previously [17] A 25-lg
amount of total RNA was incubated for 30 min at 37C
with 10 U of Dnase I/RNase-free (Roche Molecular
Bio-chemicals) in 10 mMTris/HCl pH 7.5, 10 mMMgCl2, then
samples were phenol/chloroform (1/1)
etha-nol precipitated in the presence of 0.3M sodium acetate
RNA was redissolved in sterile nuclease-free water
Differential display was performed using oligo(dT)
anchored primers [17,18] with the Hieroglyph mRNA
Profile Kit (Genomyx, Beckman Instruments, Fullerton,
CA, USA) following the manufacturer’s instructions with
some modifications First strand cDNA synthesis was
performed with 2 lL of DNase-treated total RNA
(0.1 lgÆlL)1), 2 lL of oligo(dT) anchored primer (2 lM)
and 2 lL dNTP mix (250 lM) (1 : 1 : 1 : 1) (v/v/v/v)
SuperScriptTM RNase H–Reverse Transcriptase
(Gibco-BRL Life Technologies) in 50 mMTris/HCl pH 8.3, 75 mM
KCl, 20 mM dithiothreitol in a Perkin-Elmer
Gene-Amp 9700 thermal cycler at 25C (10 min), 50 C
(60 min) and 70C (15 min) The PCR was started by
adding 2 lL of the cDNA solution to a mixture containing
9.95 lL of sterile nuclease-free water, 1.2 lL MgCl2
(25 mM), 1.6 lL dNTP mix (250 lM) (1 : 1 : 1 : 1) (v/v/v)
(Roche Molecular Biochemicals), 2 lL 5¢-arbitrary primer
(2 mM), 2 lL AmpliTaq Buffer[10· ], 0.2 lL AmpliTaq
enzyme (5 UÆlL)1) (Perkin-Elmer, Branchburj, NJ, USA),
and 0.25 lL [a-33P]dATP (10 lCiÆlL)1) Thermal cycling
parameters using a GeneAmp 9700 thermal cycler were as
follows: 95C (2 min), four cycles at 92 C (15 s), 50 C
(30 s) and 72C (2 min), 30 cycles at 92 C (15 s), 60 C
(30 s), and 72C (2 min), and an additional final extension step at 72C for 7 min Reactions were performed with each cDNA solution in duplicate Control reactions were set using sterile nuclease-free water or each DNase I-treated RNA instead of the cDNA solution
Following differential display PCR, radiolabeled cDNA fragments were electrophoretically separated on 4.5% polyacrylamide gels under denaturing conditions in a Genomix LR DNA sequencer (Genomix, Beckman) Gels were dried and exposed to produce an autoradiograph Bands of interest were excised from the gel, and the gel slides were placed directly into PCR tubes and covered with
40 lL of PCR mix (24.4 lL sterile nuclease-free water, 3.2 lL dNTP mix, 4 lL T7 promoter 22-mer primer (2 lM), 4 lL M13 reverse 24-mer primer (2 lM), 2.4 lL MgCl2 (25 mM), 4 lL AmpliTaq PCR Buffer (10·), and 0.4 lL AmpliTaq enzyme (5 UÆlL)1) PCR was performed
as follows: 95C (2 min), four cycles at 92 C (15 s), 50 C (30 s) and 72C (2 min), 30 cycles at 92 C (15 s), 60 C (30 s), and 72C (2 min), and an additional extension step
at 72C for 7 min Amplified fragments was sequenced in both directions using M13 reverse (-24) primer and T7 promoter forward (-22) primer Nucleotide sequence homology search analysis of the EMBL [19] and GenBank [20] databases were performed using theBLASTprogram [21]
RNA isolation and Northern blot analysis Total RNA from the different tissues used was isolated by the guanidinium thyocianate method [22] Aliquots (20 lg)
of total RNA were size-fractioned by electrophoresis in a 1% agarose gel under denaturing conditions RNAs were then blotted and fixed to Nytran membranes (Schleicher and Schuell, Keene, NH) Prehybridization and hybridiza-tion were performed as described previously [23] Probes were the isolated clones from differential display (0.8-kb of mRNA p53 gene and 0.9-kb of mRNA c-H-Ras gene) Equal loading of the gels was assessed using ethidium bromide staining of the gel The probes were labeled with [a32P]dCTP (3000 CiÆmmol)1) by random priming using the rediprimeTMII DNA labeling system (Amersham Pharma-cia Biotech) Specific activity was 5 · 108c.p.m.Ælg)1of DNA Quantitation was performed by densitometry of the X-ray films
Analysis of mRNA expression by RT-PCR RT-PCR was performed in one step with an Enhanced Avian RT-PCR Kit following the instructions of the manufacturer (Sigma) c-Jun expression levels were deter-mined using the following primers (5¢-TGAGTGCA AGCGGTGTCTTA-3¢ (forward) and 5¢-TAGTGGTGA TGTGCCCATG-3¢ (reverse); primers for p21WAF1/CIF1: 5¢-ACAGCGATATCGAGACACTCA-3¢ (forward) and 5¢-GTGAGACACCAGAGTGCAAGA-3¢ (reverse); pri-mers for p53: 5¢-CACAGTCGGATATGAGCATC-3¢ (forward) and 5¢-GTCGTCCAGATACTCAGCAT-3¢ (reverse) and primers for cyclin D1: 5¢-TGTTCGTGGC CTCTAAGATGA-3¢ (forward) and 5¢-GCTTGACTCCA GAAGGGCTT-3¢ (reverse); primers for 18S rRNA: 5¢-GAGTATGGTCGCAAGGCTGAA-3¢ (forward) and 5¢-GCCTCCAGCTTCCCTACACTT-3¢ (reverse) 18S
Trang 3rRNA was simultaneously amplified and used as an internal
control Routinely, RNA concentration curves were
performed to verify that the RT-PCR was quantitative
Reactions were resolved using a 2% agarose gel stained with
ethidium bromide and quantified using the Gene Genius
System Tools analysis software (SYNGENE)
Antibodies
Monoclonal (mouse) anti-p53 was purchased from
Calbiochem (Ab-3 op29), anti-c-Jun Ig and anti-RAR
(a,b,c) Ig, were purchased from Santa Cruz Biotechnology,
Inc
Immunoblot analysis
Tissues were homogenized in 10 mLÆg)1of tissue of
ice-cold buffer A [10 mM Hepes, pH 7.9, 10 mMKCl, 2 mM
MgCl2, 0.5 mM dithiothreitol, 1 mM
phenylmethane-sulfonyl fluoride, 5 mM NaF, 0.5 mM Na3VO4 and 0.1%
Triton X-100 in the presence of protease inhibitor
(5 lLÆmL)1 P8340, Sigma)]
was centrifuged at 14 000 r.p.m
To obtain the nuclear proteins, the sediment was
re-sus-pended in 3 mLÆg)1of tissue in 20 mMHepes pH 7.9, 25%
glycerol, 0.42M NaCl, 1.5 mM MgCl2, 0.2 mM EDTA,
0.5 mM dithiothreitol, 1 mM phenylmethanesulfonyl
fluoride, 5 mM NaF, 0.5 mM Na3VO4 in the presence of
protease inhibitors The suspension was incubated for
30 min on ice and centrifuged at 17 089 g
4C The supernatant was diluted with 500 lL of 20 mM
Hepes pH 7.9, 20% glycerol, 50 mMKCl, 1.5 mMMgCl2,
0.2 mM EDTA, 0.5 mM dithiothreitol, 0.5 mM
phenyl-methanesulfonyl fluoride, 5 mMNaF, 0.5 mMNa3VO4 To
obtain the cytosolic proteins, the original supernatant was
centrifuged at 15 868 g
remove mitochondria
Samples were subjected to 10% SDS/PAGE to study the
high molecular mass protein or a gradient (10–15%) SDS/
PAGE to study the low molecular mass protein In any case,
after electrophoresis, the proteins were electroblotted onto
nitrocellulose membranes (Schleicher and Schuell)
Immu-nodetection of specific proteins was made with the respective
antibody Blots were incubated in blocking solution (5% w/v
nonfat dry milk with 0.05% v/v Tween 20), for 1 h at room
temperature with shaking; following three washes with
TTBS (25 mMTris/HCl, pH 7.5, 0.15MNaCl and 0.1% v/v
Tween 20), blots were incubated with primary antibodies in
TTBS for 1 h at room temperature with gentle agitation
Blots were washed again with TTBS and incubated with the
secondary antibody conjugates to horseradish peroxidase
(Bio-Rad) for 20 min Finally, blots were washed with TTBS
and developed with a chemiluminescence kit (Lumi-Light
Western Blotting Substrate, Roche)
Immunoprecipitation of RAR-DNA complexes (chip assay)
Liver cells were isolated from control, chronic vitamin
A-deficient and hypervitaminic rats by the method of Berry
and Friend as modified by Romero and Vin˜a [24] Cells
were treated with 1% formaldehyde in Krebs–Ringer buffer
under gentle agitation for 10 min at room temperature in
order to crosslink the transcription factors to DNA The cells were collected by centrifugation at 190 g for 5 min, washed twice in 40 mL of NaCl/Pi pH 7.4, once in solution I (10 mMHepes, pH 7.5, 10 mMEDTA, 0.5 mM
EGTA, 0.75% Triton X-100) and once in solution II (10 mM Hepes pH 7.5, 200 mM NaCl, 1 mM EDTA, 0.5 mM EGTA) The cells were resuspended in 500-lL of lysis buffer (25 mM Tris/HCl pH 7.5, 150 mMNaCl, 1% Triton X-100, 0.1% SDS, 0.5% deoxycholate) supplemen-ted with protease inhibitors and then sonicasupplemen-ted on ice for 10 steps of 10 s at 30% output in a Branson 250 Sonicator (with microtip) The samples were centrifuged at 19 000 g for 2 min to clear the supernatants The supernatants were transferred to an eppendorf tube and centrifuged at
19 000 g for 10 min The lysates were diluted tenfold in lysis buffer and stored at )20 C in aliquots of 1 mL (sample named as input)
The immunofractionation of RAR–DNA complexes was performed by addition of 10 lgÆmL)1of RARc antibody (Santa Cruz Biotechnology, sc-773) and incubation at 4C overnight (on a 360 rotator) The inmunocomplexes were incubated with 10 mg of protein A Sepharose, prewashed with lysis buffer for 4 h at 4C under gentle rotation The immunocomplexes were collected by centrifugation (6500 g, 1 min) The supernatant was stored at )20 C This fraction was named the unbound fraction Antibody-bound fraction was washed once with RIPA buffer (50 mM
Tris/HCl pH 8.0, 150 mMNaCl, 0.5% deoxycholate, 0.1% SDS, 1% NP-40, 1 mMEDTA), once with high salt buffer (50 mMTris HCl pH 8.0, 500 mMNaCl, 0.1% SDS, 0.5% deoxycholate, 1% NP-40, 1 mM EDTA) once with LiCl buffer (50 mM Tris/HCl pH 8.0, 1 mM EDTA, 250 mM
LiCl, 1% de NP-40, 0.5% deoxycholate) and twice with Tris/EDTA
17 buffer pH 8.0 The cross-links were reversed by heating the samples at 65C overnight The DNA from all fractions (input, bound and unbound) were extracted with phenol/chloroform (1/1)
with PicoGreen dye (Molecular Probes)
Analysis of immunoprecipitated DNA
To check that the immunoprecipitation contains the c-Jun promoter among the pull of DNA, the different DNA samples (input, bound and unbound) were analyzed
by PCR using the primers 5¢-TGTAACCTCTACTCCCA CCCA-3¢ (forward) and 5¢-TCTGAGTCCTTATCCAGC CTG-3¢ (reverse) corresponding to a region of the c-Jun promoter that expands between the start transcription site and the)504 position
Statistics
In the experiment shown in the Table 1, a two-wayANOVA
was performed; in the other experiments, a one-wayANOVA
was performed The homogeneity of the variances was analyzed by the Levene test; in those cases in which the variances were unequal, the data were adequately transformed before the ANOVA The null hypothesis was accepted for all the values of these sets in which the F-value was nonsignificant at P > 0.05 The data for which the F-value was significant were examined by the Tukey’s test at P < 0.05 Values in the text are means ± SEM
Trang 4Physiological parameters and all-trans retinol
and all-trans retinyl palmitate concentrations
in plasma and tissues
After delivery, dams were fed either a control diet or a
vitamin A-deficient diet for 50 days Milk production was
evaluated at the peak of lactation in both groups, and no
difference was found After weaning, the pups either ate the
control diet or the vitamin A-deficient diet; no statistical
difference in body weight or food intake was found between
groups In control rats injected daily with all-trans retinyl
palmitate over a period of 5 days, food intake was also not
different from control rats
All-trans retinol plasma concentration was decreased
significantly in chronic vitamin A deficiency when
com-pared to control rats (Table 1) In the liver of vitamin
A-deficient rats, all-trans retinol and all-trans retinyl
palmi-tate were decreased significantly when compared to control
livers In lung from vitamin A-deficient rats, all-trans-retinyl
palmitate was decreased significantly when compared to
control lungs (Table 1) When rats were injected daily over a
period of 5 days with retinyl palmitate, the concentration of
this compound was significantly higher in plasma, liver and
lung when compared to controls
Liver gene expression evaluated by differential display
in control and in chronic vitamin A-deficiency
Liver differential display analysis was performed in control
and chronic vitamin A-deficient rats (50 days) Several
bands were differentially expressed in chronic vitamin
A-deficiency when compared to control liver Two of the
bands selected for analysis, whose expression were
differ-entialy expressed in chronic vitamin A-deficiency, were
excised from the gel, amplified and sequenced (Fig 1) The
first clone of 0.8 kb had 100% homology to part of the
rat p53 cDNA and could hybridize to a 1.6-kb mRNA in
total cellular RNA from rat liver The band detected in
Northern blot by the first clone corresponded in size to that
reported for rat p53 and was up-regulated fivefold when
compared with control rat liver, thus confirming the
up-regulation detected in the differential display gel The
second clone of about 0.9 kb had 100% homology to part
of the rat c-H-Ras cDNA and hybridized with a 1.7-kb mRNA in total RNA from rat liver This gene was down-regulated sixfold when compared with control rat liver (Fig 1), showing an opposite expression pattern to that of the p53 gene
RT-PCR analysis ofc-jun, p53 and p21WAF1/CIF1in liver and lung of control, chronic vitamin A-deficiency and hypervitaminosis rats
Based on the results found in the differential display study and taking into account the role that p53 plays in the control
of cellular proliferation, the expression levels of p53, c-Jun (a negative regulator of p53) and p21WAF1/CIF1 (positively regulated by p53) were evaluated in liver by RT-PCR analysis The mRNA levels in liver (Fig 2) and in lung (Fig 3) of p53 and of p21WAF1/CIF1 were significantly increased in vitamin A-deficient rats when compared to controls but the expression of c-Jun was significantly lower when compared to controls When retinyl palmitate was injected daily over a period of 5 days, the expression levels of p53 and p21WAF1/CIF1were significantly lower than
in controls while the expression level of c-Jun was signifi-cantly higher than in control (Figs 2 and 3)
Western blot analysis in liver and lung of control, chronic vitamin A-deficiency and hypervitaminosis rats Liver and lung samples were electrophoresed and immuno-blotted with specific antibodies The amount of p53 protein was significantly higher in chronic vitamin A-deficient rats than in controls, while the amount of c-Jun was significantly lower in chronic vitamin A-deficiency as compared to controls In hypervitaminosis the amount of p53 was significantly lower than in controls, whereas the amount
of c-Jun was significantly higher than in controls (Fig 4) These changes in the pattern levels followed the pattern of p53 and c-Jun gene expression showed in Figs 2 and 3 Immunoprecipitation of complex RAR–DNA
To elucidate the mechanism of this pattern of expression, the binding of RAR to c-Jun promoter was studied using the immunoprecipitation of complex RAR–DNA with a polyclonal antibody reactive to RARa, RARb and RARc
Table 1 Retinol concentrations in plasma and tissues from control, vitamin-A deficient and hypervitaminosis rats Values are means ± SEM, with the numbers of animals indicated in parentheses Different superscript letters within a row indicate significant differences, P < 0.05 ND, not detected.
PLASMA (l M )
All-trans retinol 2.99 ± 0.48 (6) a 0.46 ± 0.10 (4) c 1.61 ± 0.12 (5) b
TISSUES (lg/g)
Liver
All–trans retinol 2.88 ± 0.48 (6)b 0.18 ± 0.03 (2)c 78.08 ± 15.40 (3)a All–trans retinyl palmitate 64.66 ± 10.97(6) b 5.60 ± 1.66 (4) c 4276 ± 1334 (5) a
Lung
All–trans retinyl palmitate 2.99 ± 0.32 (4) b 0.64 ± 0.11 (4) c 262.74 ± 35.55 (5) a
Trang 5DNA was extracted from the input, bound and unbound
fractions; equal amounts from each fraction were analyzed
using primers that amplify the c-Jun promoter region
between the start transcription site and the)504 position
The amplified DNA was resolved by agarose gel
electro-phoresis The specific binding was determined by the relative
intensity of ethidium bromide fluorescence when compared
to the input control Our data show that the RAR binding was almost undetectable in vitamin A-deficiency when compared to controls, while in acute hypervitaminosis the binding was significantly higher These changes in the RAR–DNA binding is not due to different levels of the retinoic acid receptor induced by the treatment, as RAR expression was similar in control, vitamin A-deficiency and hypervitaminosis (Fig 5) rats An antibody against a protein unrelated to vitamin A was used as a mock control and binding was not observed (results not shown)
Discussion
Using differential display analysis, it has been shown in the liver of chronic-vitamin A deficient rats that the expression
of p53 was significantly higher when compared to control rats It was also found that expression of c-H-Ras was significantly lower in chronic vitamin A-deficient rats than
in controls Based on these findings, c-Jun, a proto-oncogene, that encodes a component of the mitogen-inducible immediate early transcription factor, AP-1 and has that been implicated as a positive regulator of cell proliferation
Fig 2 Expression of c-Jun, p53 and p21WAF1/CIF1in liver (C) control rats (D) vitamin A-deficient and (H) hypervitaminosis Total RNA was isolated for each condition amplified by RT-PCR using specific primers for p53, c-Jun, p21 and for 18S rRNA as described in Mate-rials and methods *P < 0.05.
Fig 1 Detection of differential gene expression induced bychronic
vitamin A-deficiencyin rats Panel A, sequencing gel electrophoresis of
PCR amplified cDNAs performed in duplicate, from control (C) and
vitamin A-deficient rats (D) A differentially displayed fragment
(arrow) was detected, isolated, and identified as a 0.8-kb fragment of
p53 cDNA Northern blot analysis of total RNA from control and
vitamin A-deficient rats with p53 cDNA fragment confirmed its
dif-ferential expression Panel B, another differentially displayed fragment
was detected, isolated and identified as a 0.9-kb fragment of c-H-Ras
cDNA Northern blot analysis of total RNA confirmed its differential
expression.
Trang 6and G1–S phase progression [24,26], was analyzed by
RT-PCR As expected, in chronic-vitamin A-deficiency,
c-Jun was significantly lower than in control animals as
it negatively regulates transcription of p53 by binding
directly to a variant AP1 site in the p53 promoter [25] As
p21WAF1/CIP1 encodes a cyclin dependent kinase inhibitor
that is a critical target of p53 in facilitating G1arrest, we also
studied the expression of p21WAF1/CIP1, and found that it is
increased in chronic-vitamin A deficiency when compared
to control rats Using Western blot analysis it was also
found that p53 protein was increased and c-Jun protein was
decreased in liver chronic-vitamin A deficient rats when
compared to controls No apoptosis was found in liver of
chronic-vitamin A deficiency because the typical
ladder-type DNA pattern of nuclear apoptosis was not observed
and also no cytochrome c was detected in the cytosol (data
not shown) All these results found in chronic vitamin A
deficient rats suggest that the increase of p53, results in
arrest of progression through the cell cycle [27] In rats
Fig 4 Western blot analysis of p53 and c-Jun in liver and lung Total protein extracts were obtained as described in experimental proce-dures A single band of about 53 kDa was detected in liver and lung indicating that the amount of p53 protein was significantly increased in the liver and lung from vitamin A-deficient rats that in controls c-Jun protein was significantly decreased in vitamin A-deficient rats In the liver of rats with hypervitaminosis the results showed a decrease in the amount of p53 and an increase of the c-Jun The figure shows that the expression of p53 is time course dependent C, control; D, vitamin A-deficient rats; H, hypervitaminosis.
Fig 3 Expression of c-Jun, p53 and p21 WAF1/CIF1 in lung (C) control
rats (D) vitamin A-deficient rats (H) hypervitaminosis Total RNA
was isolated for each condition amplified by RT-PCR using specific
primers for p53, c-Jun, p21 and for 18S rRNA as described in
Mate-rials and methods *P < 0.05.
Trang 7injected with a high-dose of vitamin A over a period of
5 days, c-jun was increased and p53 and p21WAF1/CIP1were
significantly lower when compared to controls
Overexpression of c-Jun alters cell cycle parameters and
increases the proportion of cells in S, G2and M relative to
G0phases of the cell cycle The role of c-Jun in promoting
cell growth has been highlighted from studies of c-Jun
deficient mouse embryonic fibroblasts [27] Fibroblasts
lacking c-Jun exhibit a severe proliferation defect, because
these cells accumulate the tumor suppressor, p53 and its
downstream target, the cyclin-dependent kinase inhibitor
p21WAF1/CIF1, suggesting that one particular function of
c-Jun is the negative regulation of p53 transcription The
fact that the binding of RAR to the c-Jun promoter is
affected by the vitamin A status and that no changes in the
RAR amount were observed, suggests that c-Jun is under
direct control of retinoic acid However, c-Jun expression
can be also regulated by Ras by means of the MAPkinase
pathway [28] and this mechanism could explain in part
the decreased expression of c-Jun found in
chronic-vitamin A-deficient rats
explains the decrease in C-H-Ras expression found in
chronic-vitamin A deficient rats is unknown at the present
time
The role of vitamin A status in the expression of genes
related to the regulation of cell proliferation has been
studied in vivo and in vitro, and shows that retinoids play an
important role in proliferation and differentiation Using
mice deficient in retinaldehyde dehydrogenase-2 it has been shown that retinoic acid synthesized by the postimplanta-tion mammalian embryo is an essential developmental hormone whose absence leads to early embryonic death [7]
In rat Sertoli cells, a significant up-regulation in c-Jun (beginning at 30 min and reaching a fourfold peak over controls at 1 h) has been observed [9] Our results, in an
in vivo model, are in agreement with these observations because c-Jun, p53 and p21WAF1/CIF1are modulated in liver
by the vitamin A status Moreover, this modulation in part can be produced by the control that the retinoic acid exerts
on c-Jun expression
All the results found in liver were reproduced in lung, which can explain in part the conflicting results found in adults and children given b-carotene or vitamin A [29] Moreover, in lung of rats injected with high-dose of vitamin A over a period of 5 days, the overexpression of c-Jun, produced a significant increase in the cyclin D1 expression, a positive regulator of G1–S phase transition (Fig 6) These results and the fact that the transcription of p53and p21 were significantly decreased as well as the levels
of the p53 protein may indicate that the exposure to b-carotene can increase the carcinogenesis risk Epidemio-logic studies in humans suggest that high consumption of fruits and vegetables is associated with a reduced risk of chronic diseases including cancer and cardiovascular disease [30–33] Recently, it has been shown in two cohort studies that a-carotene and lycopene intakes were significantly
Fig 5 Immunoprecipitation of complex RAR-DNA and c-Jun promoter detection Panel A, the binding of RAR to c-Jun promoter was studied using the immunoprecipitation of complex RAR-DNA with a polyclonal antibody reactive to RARa, RARb and RARc, as described in Experimental procedures DNA was extracted from the input, bound and unbound fractions; equal amounts from each fraction were analyzed using primers that amplify the c-Jun promoter region between the start transcription site and the )504 position, the amplified DNA were resolved by agarose electrophoresis The intensity of fluorescent dye, ethydium bromide, relative to the intensity from the input gives the enrichment generated by the antibody selection Panel B: detection of RAR by Western blotting C, control; D, vitamin A-deficient rats; H, hypervitaminosis.
Trang 8associated with a lower risk of lung cancer, and the intakes
of b-carotene, lutein and b-cryptoxanthin were also
associ-ated with a lower risk but it was not significant Even in
smokers, a significant reduction in cancer risk was noted in
association with increased lycopene intake [34] However,
The a-Tocopherol b-Carotene (ATBC) trial [35] and the
b-Carotene and Retinol Efficacy Trial (CARET) [36]
revealed that individuals that were given b-carotene and
vitamin A received no protection from cancer and there
may even have been an adverse effect on the incidence of
lung cancer (and on the risk of death from lung cancer) and
due to any cause in smokers and workers exposed to
asbestos
20 In another trial (Physician’s Health Study), the
supplementation with b-carotene to male physicians during
a 12-year-span produced neither benefits nor harm in terms
of the incidence of cancer, cardiovascular disease, or death
from all causes [37]
21 The failure of these studies to
demon-strate that large b-carotene supplement has a protective role
has been explained by several factors: (a) the high tissue
b-carotene concentrations (as much as 50-fold higher than
those observed in a normal population that eat large
amounts of fruits and vegetables) may had adverse effects
and interactions that were not observed at the lower
con-centrations obtained with diet [38]; (b) individual variation
in serum response to administration among subjects given
an identical dose of b-carotene [38]; (c) interference with the
uptake, transport, distribution, and/or metabolism of other
nutrients; (d) high levels of carotene and the products of its
oxidation may act as prooxidants; (e) the alcohol intake of
the subjects
25 studied [35,39,40] and (f) the different
bioavail-ability found when a single high dose is used when
compared to the mixtures found when fruit and vegetables
are eaten [38] All these facts emphasize that fruit and
vegetable intakes are more convenient than an increased
intake of a single drug-like chemopreventive carotenoid
[41] In ferrets, the hazard association of high-dose
b-carotene supplementation and tobacco smoking is
asso-ciated with elevated carotene oxidation products in lung
tissues, significantly lower concentrations of retinoic acid
and reductions (18–73%) in bRAR gene expression Ferrets
given a diet supplemented
tobacco smoke had an increased expression of c-Jun and
c-Fosgenes [41,42] Our work provides a mechanism that
may explain in part the regulation of control of proliferative
genes that cause an increased incidence of cancer in smokers supplemented with b-carotene This mechanism (Fig 7) consists of the direct regulation that exerts the retinoic acid
on c-Jun expression
23 The increased levels of c-Jun induce a positive effect in the expression of the cyclin D1 gene and the down-regulation of p53
Our results explain the importance of keeping vitamin A status within the normal range, because p53 tumor suppressor protein, a transcription factor involved in maintaining genomic integrity by controlling cell cycle progression and cell survival, changes its expression at different vitamin A levels
Acknowledgements The authors thank Luis Franco for advice and valuable comments This work has been supported by FIS 99/1157, BFI2001-2842, CICYT-Comisio´n Europea (1FD97-1336), Generalitat Valenciana and
PB97-1368 from DGICYT, Ministerio de Educacio´n y Cultura (Spain) Projectes Precompetitius Universitat de Vale`ncia (68200) and Redes de Investigacion Cooperation Instituto Carlos III (RC03-08) R Z is supported by a predoctoral fellowship of the Ministerio de Educacio´n y Cultura Spain M M is supported by a predoctoral fellowship of the Consellerı´a de Cultura Educacio´ i Cie`ncia, Generalitat Valenciana. References
1 Chambon, P (1996) A decade of molecular biology of retinoic acid receptors FASEB J 10, 940–954.
2 Evans, T.R.J & Kayne, S.B (1999) Retinoids; present role and future potential Br J Cancer 80, 1–8.
3 Chen, Y., Derguini, F & Buck, J (1997) Vitamin A in serum is a survival factor for fibroblasts Proc Natl Acad Sci 94, 10205– 10208.
4 Mason, K.E (1935) Foetal death, prolonged gestation and diffi-cult parturition in the rat as a result of vitamin A deficiency Am J Anat 57, 303–349.
Fig 6 Induction of cyclin D1 in lung Total RNA was isolated for each
condition amplified by RT-PCR using specific primers for cyclin D1
and for 18S rRNA as described in Materials and methods *P < 0.05.
C, control rats; H, rats with a high-dose of vitamin A over a period of
5 days.
Fig 7 Diagrammatic representation of the changes induced in the control of proliferative genes byvitamin A Within the nucleus, retinoic acid binds to RAR/RXR (heterodimeric retinoic acid-receptors) The ligand-attached receptors then bind to the retinoic acid-receptor ele-ment of the c-Jun promoter, thereby activating its expression The increased levels of c-Jun up-regulate cyclin D 1 expression and inhibit the transcription of p53 and p21.
Trang 95 Hale, F (1937) The relation of maternal vitamin A deficiency to
microphthalmia in pigs Texas State J Med 33, 228–232.
6 Zile, M.H (2001) Function of vitamin A in vertebrate embryonic
development J Nutr 131, 705–708.
7 Niederreither, K., Subbarayan, V., Dolle´, P & Chambon, P.
(1999) Embryonic retinoic acid synthesis is essential for early
mouse post-implantation development Nature Genet 21, 444–
448
24
8 Batourina, E., Gim, S., Bello, N., Shy, M., Clagett-Dame, M.,
Srinivas, S., Costantini, F & Mendelsohn, C (2001) Vitamin A
controls epithelium/mesenchymal interactions through Ret
expresion Nature Genet 27, 74–78.
9 Page, K.C., Heitzman, D.A & Chernin, M.I (1996) Stimulation
of c-jun and c-myb in rat Sertoli cells following exposure to
retinoids Biochem Biophys Res Comm 225, 595–600.
10 Monagham, B.R & Schmitt, F.O (1932) The effects of carotene
and of vitamin A on the oxidation of linoleic acid J Biol Chem.
96, 387–395.
11 Ciaccio, M., Valenza, M., Tesoriere, L., Bongiorno, A., Albiero,
R & Livrea, M.A (1993) Vitamin A inhibits doxorubicin-induced
membrane lipid peroxidation in rat tissues in vivo Arch Biochem.
Biophys 90, 103–108.
12 Palacios, A., Piergiacomi, V.A & Catala´, A (1996) Vitamin A
supplementation inhibits chemiluminescence and lipid
peroxida-tion in isolated rat liver micrososmes and mitochondria Mol Cell
Biochem 154, 77–82.
13 Barber, T., Borra´s, E., Torres, L., Garcı´a, C., Cabezuelo, F.,
Lloret, A., Pallardo´, F.V & Vin˜a, J.R (2000) Vitamin A
defi-ciency causes oxidative damage to liver mitochondria in rats Free
Rad Biol Med 29, 1–7.
14 Murata, M & Kawanishi, S (2000) Oxidative DNA damage by
vitamin A and its derivate via superoxide generation J Biol.
Chem 275, 2003–2008.
15 Siaems, W., Sommerburg, O., Schild, L., Augustin, W., Langhans,
C.D & Wiswedel, I (2002) b-Carotene cleavage products induce
oxidative stress in vitro by impairing mitochondrial respiration.
FASEB J 16, 1289–1291.
16 Barua, A.B & Olson, J.A (1998) Reversed-phase gradient high
performance liquid chromatographic procedure for simultaneous
analysis of very polar to non-polar retinoids, carotenoids and
tocopherols in animals and plant samples J Chromatogr B 707,
69–79.
17 Otero, G., Avila M.A., De la Pen˜a, L., Emfietzoglou, J.,
Cansado, G.F & Popescu, and Notario, V (1997) Altered
pro-cessing of precursor transcripts and increased levels of the subunit
I of mitochondrial cytochorme c oxidase in syrian hamster fetal
cells initiated with ionizing radiation Carcinogenesis 18, 1569–
1775.
18 Liang, P & Pardee, A.B (1992) Differential display of eukaryotic
messenger RNA by means of the polymerase chain reaction.
Science 257, 967–971.
19 Hamon, G.H & Cameron, G.N (1986) The EMBL data library.
Nucleic Acids Res 14, 5–10.
20 Bilofsky, H.S., Burks, C & The GenBank data bank (1988) Nucl
Acids Res 16, 1861–1864.
21 Pearson, W.R & Lipmann, D.J (1988) Improved tools for
bio-logical sequences comparison Procl Natl Acad Sci USA 85,
2444–2448.
22 Chomczynski, P & Sacchi, N (1987) Single-step method for RNA
isolation by acid guanidium thiocyanate-phenol-chloroform
extraction Anal Biochem 162, 156–159.
23 Thomas, P.S (1980) Hybridization of denatured RNA and small
DNA fragments transferred to nitrocellulose Proc Natl Acad.
Sci USA 162, 156–159.
24 Romero, F.J & Vin˜a, J (1983) A simple procedure for the
pre-paration of isolated liver cells Biochem Educ 11, 135–136.
25 Schreiber, M., Kolbus, A., Piu, F., Szabowski, A., Mo¨hle-Stein-lein, U., Tian, J., Karin, M., Angel, P & Wagner, E.F (1999) Control of cell cycle progression by c-jun is p53 dependent Genes Dev 13, 607–619.
26 Wisdom, R., Johnson, R.S & Moore, C (1999) c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms EMBO J 18, 188–197.
27 Griffiths, J.K (2000) The vitamin A paradox J Pediatr 137, 604– 607.
28 Mechta-Grigoriou, F., Gerald, D & Yaniv, M (2001) The mammalian Jun proteins: redundancy and specificity Oncogene
20, 2378–2389.
29 Peto, R., Doll, R., Buckley, J.D & Sporn, M.B (1981) Can dietary beta carotene materially reduces human cancer rates? Nature 290, 201–208.
30 Block, G., Patterson, B & Subar, A (1992) Fruit, vegetables and cancer prevention: a review of the epidemiologic evidence Nutr Cancer 18, 1–29.
31 Ames, B.N., Gold, L.S & Willett, W.C (1995) The causes and prevention of cancer Proc Natl Acad Sci USA 92, 5258–5265.
32 Ames, B.N & Gold, L.S (1997) Environmental pollution, pesti-cides, and the prevention of cancer: misconceptions FASEB J 11, 1041–1052.
33 Michaud, D.S., Feskanich, D., Rimm, E.B., Colditz, G.A., Spe-izer, F.E., Willett, W.C & Giovannuci, E (2000) Intake of specific carotenoids and risk of lung cancer in 2 prospective US cohorts.
Am J Clin Nutr 72, 990–997.
34 Albanes, D., Heinonen, O.P., Taylor, P.R., Virtamo, J., Edwards, B.K., Rauthalathi, M., Hartman, A.M., Palmgren, J., Freedman, L.S., Haapakoski, J., Barrett, M.J., Pietinen, P., Malila, N., Liipo, K., Salomaa, E.R., Tangrea, J.A., Teppo, L., Askin, F.B., Erozan, Y., Greenwald, P & Huttunen, J.K (1996) Tocopherol and carotene supplements and lung cancer incidence in the alpha tocopherol, beta carotene cancer prevention study: effects of base line characteristics and study compliance J Natl Cancer Inst 88, 1560–1570.
35 Omenn, G.S., Goodman, G.E., Thornquist, M.D., Balmes, J., Cullen, M.R., Glass, A., Keogh, J.P., Meyskens, F.L., Valanis, B., Williams, J.H., Barnhart, S & Hammar, S (1996) Effects of a combination of beta-carotene and vitamin A on lung cancer and cardiovascular disease N Engl J Med 334, 1150–1155.
36 Hennekens, C.H., Buring, J.E., Manson, J.E., Stampfer, M., Rosner, B., Cook, N.R., Belanger, C., LaMotte, F., Gaziano, J.M., Ridker, P.M., Willet, W & Peto, R (1996) Lack of effect of long-term supplementation with beta-carotene on the incidence of malignant neoplasma and cardiovascular disease N Engl J Med.
334, 1145–1149.
37 Pryor, W.A., Stahl, W & Rock, C.L (2000) Beta-carotene: from biochemistry to clinical trials Nutr Rev 58, 39–53.
38 Bowen, P.E., Mobarhan, S & Smith, J.C Jr (1993) Carotenoid absorption in humans Methods Enzymol 214, 3–16.
39 Omenn, G.S., Goodman, G.E., Thornquist, M.D., Balmes, J., Cullen, M.R., Glass, A., Keogh, J.P., Meyskens, F.L., Valanis, B., Williams, J.H., Barnhart, S., Cherniack, M.G., Brodkin, C.A & Hammar, S (1996) Risk factors for lung cancer and for inter-ventions effects in CARET, beta-carotene and retinol efficacy trial.
J Natl Cancer Inst 88, 1550–1559.
40 Heber, D (2000) Colorful cancer prevention: alpha carotene, lycopene and lung cancer Am J Clin Nutr 72, 901–902.
41 Wang, X.D., Liu, C., Bronson, B.T., Smith, D.E., Krinsky, N.I & Russell, R.M (1999) Retinoid signaling and activator protein-1 expression in ferrets given carotene supplements and exposed to tobacco smoke J Natl Cancer Inst 91, 60–66.
42 Wolf, G (2002) The effect of low and high doses of b-carotene and exposure to cigarette smoke on lungs of ferrets Nutrition Rev 60, 88–90.